TY - JOUR AU - Haffner, S. M. AU - Lehto, S. AU - Ronnemaa, T. PY - 1998 DA - 1998// TI - Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction JO - New Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199807233390404 DO - 10.1056/NEJM199807233390404 ID - Haffner1998 ER - TY - JOUR AU - Dagogo-Jack, S. AU - Santiago, J. V. PY - 1997 DA - 1997// TI - Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions JO - Arch Int Med VL - 103 UR - https://doi.org/10.1001/archinte.157.16.1802 DO - 10.1001/archinte.157.16.1802 ID - Dagogo-Jack1997 ER - TY - JOUR AU - Eschwege, E. AU - Richard, J. L. AU - Thibult, N. PY - 1985 DA - 1985// TI - Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris prospective study, ten years later JO - Horm Metab Res VL - 15 ID - Eschwege1985 ER - TY - JOUR AU - Despres, J. P. AU - Lamarche, B. AU - Mauriege, P. PY - 1996 DA - 1996// TI - Hyperinsulinemia as an independent risk factor for ischemic heart disease JO - New Engl J Med VL - 334 UR - https://doi.org/10.1056/NEJM199604113341504 DO - 10.1056/NEJM199604113341504 ID - Despres1996 ER - TY - JOUR AU - Haffner, S. M. AU - Miettinen, H. PY - 1997 DA - 1997// TI - Insulin resistance implications for type II diabetes mellitus and coronary heart disease JO - Am J Med VL - 103 UR - https://doi.org/10.1016/S0002-9343(97)00027-2 DO - 10.1016/S0002-9343(97)00027-2 ID - Haffner1997 ER - TY - JOUR AU - Reaven, G. M. PY - 1991 DA - 1991// TI - Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease JO - Am Heart J VL - 121 UR - https://doi.org/10.1016/0002-8703(91)90434-J DO - 10.1016/0002-8703(91)90434-J ID - Reaven1991 ER - TY - JOUR AU - Rett, K. PY - 1999 DA - 1999// TI - The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome JO - Diabetes Obes Metab VL - 1 UR - https://doi.org/10.1046/j.1463-1326.1999.0010s1008.x DO - 10.1046/j.1463-1326.1999.0010s1008.x ID - Rett1999 ER - TY - JOUR AU - Festa, A. AU - D’Agostino, R. AU - Howard, G. PY - 2000 DA - 2000// TI - Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS) JO - Circulation VL - 102 ID - Festa2000 ER - TY - JOUR AU - Mokdad, A. H. AU - Serdula, M. k. AU - Dietz, W. H. PY - 1999 DA - 1999// TI - The spread of the obesity epidemic in the United States, 1991-1998 JO - JAMA VL - 282 UR - https://doi.org/10.1001/jama.282.16.1519 DO - 10.1001/jama.282.16.1519 ID - Mokdad1999 ER - TY - JOUR AU - Must, A. AU - Spradano, J. AU - Coakley, E. H. PY - 1999 DA - 1999// TI - The disease burden associated with overweight and obesity JO - JAMA VL - 282 UR - https://doi.org/10.1001/jama.282.16.1523 DO - 10.1001/jama.282.16.1523 ID - Must1999 ER - TY - JOUR AU - Kwiterovich, P. O. PY - 2000 DA - 2000// TI - The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review JO - Am J Cardiol VL - 86 UR - https://doi.org/10.1016/S0002-9149(00)01461-2 DO - 10.1016/S0002-9149(00)01461-2 ID - Kwiterovich2000 ER - TY - JOUR AU - Goldberg, R. B. AU - Capuzzi, D. PY - 2001 DA - 2001// TI - Lipid disorders in type 1 and type 2 diabetes JO - Clin Lab Med VL - 21 ID - Goldberg2001 ER - TY - JOUR AU - Superko, H. R. PY - 1999 DA - 1999// TI - Small, dense low-density lipoprotein subclass pattern B: issues for the clinician JO - Curr Atheroscler Rep VL - 1 UR - https://doi.org/10.1007/s11883-999-0050-6 DO - 10.1007/s11883-999-0050-6 ID - Superko1999 ER - TY - JOUR AU - O’Keefe, J. H. AU - Miles, J. M. AU - Harris, W. H. PY - 1999 DA - 1999// TI - Improving the adverse cardiovascular prognosis of type 2 diabetes JO - Mayo Clin Proc VL - 74 UR - https://doi.org/10.4065/74.2.171 DO - 10.4065/74.2.171 ID - O’Keefe1999 ER - TY - CHAP AU - Knopp, R. H. ED - Gotto, A. M. PY - 2000 DA - 2000// TI - Current concepts in dietary therapy for dyslipidemia BT - Mediguide to Heart Diseases PB - Lawrence DellaCorte CY - New York ID - Knopp2000 ER - TY - JOUR AU - O’Keefe, J. H. AU - Harris, W. S. PY - 2000 DA - 2000// TI - From inuit to implementation: omega-3 fatty acids come of age JO - Mayo Clin Proc VL - 75 ID - O’Keefe2000 ER - TY - JOUR AU - Shikany, J. M. AU - White, G. L. PY - 2000 DA - 2000// TI - Dietary guidelines for chronic disease prevention JO - South Med J VL - 93 ID - Shikany2000 ER - TY - JOUR AU - Lynch, J. AU - Helmrich, S. P. AU - Lakka, T. A. PY - 1996 DA - 1996// TI - Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men JO - Arch Int Med VL - 156 UR - https://doi.org/10.1001/archinte.156.12.1307 DO - 10.1001/archinte.156.12.1307 ID - Lynch1996 ER - TY - JOUR AU - Henry, R. R. PY - 1996 DA - 1996// TI - Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus JO - Ann Int Med VL - 124 ID - Henry1996 ER - TY - JOUR PY - 1998 DA - 1998// TI - Evaluation, and Treatment of Overweight and Obesity in Adults JO - Arch Int Med VL - 158 ID - ref20 ER - TY - JOUR AU - Davidson, M. H. AU - Hauptman, J. AU - DiGirolamo, M. PY - 1999 DA - 1999// TI - Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial JO - JAMA VL - 281 UR - https://doi.org/10.1001/jama.281.3.235 DO - 10.1001/jama.281.3.235 ID - Davidson1999 ER - TY - JOUR AU - Heymsfield, S. B. AU - Segal, K. R. AU - Hauptman, J. PY - 2000 DA - 2000// TI - Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults JO - Arch Int Med VL - 160 UR - https://doi.org/10.1001/archinte.160.9.1321 DO - 10.1001/archinte.160.9.1321 ID - Heymsfield2000 ER - TY - JOUR AU - Lindgarde, F. PY - 2000 DA - 2000// TI - The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish multimorbidity study JO - J Int Med VL - 248 UR - https://doi.org/10.1046/j.1365-2796.2000.00720.x DO - 10.1046/j.1365-2796.2000.00720.x ID - Lindgarde2000 ER - TY - JOUR AU - Grosskopf, I. AU - Ringel, Y. AU - Charach, G. PY - 1997 DA - 1997// TI - Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjects JO - Diabetes Care VL - 20 UR - https://doi.org/10.2337/diacare.20.10.1598 DO - 10.2337/diacare.20.10.1598 ID - Grosskopf1997 ER - TY - JOUR AU - Charles, M. A. AU - Morange, P. AU - Eschwege, E. PY - 1998 DA - 1998// TI - Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO 1 Study JO - Diabetes Care VL - 21 UR - https://doi.org/10.2337/diacare.21.11.1967 DO - 10.2337/diacare.21.11.1967 ID - Charles1998 ER - TY - JOUR AU - Mather, K. J. AU - Verma, S. AU - Anderson, T. J. PY - 2001 DA - 2001// TI - Improved endothelial function with metformin in type 2 diabetes mellitus JO - Circulation VL - 37 ID - Mather2001 ER - TY - BOOK AU - Defronzo, R. A. PY - 2001 DA - 2001// TI - Treatment of type 2 diabetes mellitus: a sound approach based upon its pathophysiology PB - Academy of Medicine of New Jersey CY - Lawrenceville ID - Defronzo2001 ER - TY - JOUR AU - Parulkar, A. A. AU - Pendergrass, M. L. AU - Granda-Ayala, R. PY - 2001 DA - 2001// TI - Nonhypoglycemic effects of thiazolidinedones JO - Ann Int Med VL - 134 ID - Parulkar2001 ER - TY - JOUR PY - 2000 DA - 2000// TI - Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200001203420301 DO - 10.1056/NEJM200001203420301 ID - ref29 ER - TY - JOUR AU - Hansson, L. AU - Lindholm, L. H. AU - Niskanenn, L. PY - 1999 DA - 1999// TI - Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) Randomized Trial JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)05012-0 DO - 10.1016/S0140-6736(98)05012-0 ID - Hansson1999 ER - TY - JOUR AU - Baron, A. D. PY - 1999 DA - 1999// TI - Vascular reactivity JO - Amer J Cardiol VL - 84 UR - https://doi.org/10.1016/S0002-9149(99)00354-9 DO - 10.1016/S0002-9149(99)00354-9 ID - Baron1999 ER - TY - JOUR AU - Petrie, J. R. AU - Ueda, S. AU - Webb, D. J. PY - 1996 DA - 1996// TI - Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease JO - Circulation VL - 93 ID - Petrie1996 ER - TY - JOUR AU - Schmidt, M. I. AU - Duncan, B. B. AU - Sharrett, A. R. PY - 1999 DA - 1999// TI - Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(99)01046-6 DO - 10.1016/S0140-6736(99)01046-6 ID - Schmidt1999 ER - TY - JOUR AU - Haffner, S. M. AU - Alexander, C. M. AU - Cook, T. J. PY - 1999 DA - 1999// TI - Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study JO - Arch Int Med VL - 159 UR - https://doi.org/10.1001/archinte.159.22.2661 DO - 10.1001/archinte.159.22.2661 ID - Haffner1999 ER - TY - JOUR AU - Freeman, D. J. AU - Norrie, J. AU - Sattar, N. PY - 2001 DA - 2001// TI - Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the west of Scotland Coronary Prevention Study JO - Circulation VL - 103 ID - Freeman2001 ER - TY - JOUR AU - Knopp, R. H. PY - 1999 DA - 1999// TI - Drug treatment of lipid disorders JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199908123410707 DO - 10.1056/NEJM199908123410707 ID - Knopp1999 ER - TY - JOUR AU - Manninen, V. AU - Tenkanen, L. AU - Koskinen, P. PY - 1992 DA - 1992// TI - Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment JO - Circulation VL - 85 ID - Manninen1992 ER - TY - JOUR AU - Rubins, H. B. AU - Robins, S. J. AU - Collins, D. PY - 1999 DA - 1999// TI - Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199908053410604 DO - 10.1056/NEJM199908053410604 ID - Rubins1999 ER - TY - STD TI - Effect of Fenofibrate on Progression of Coronary Artery Disease in Type 2 Diabetes: The Diabetes Atherosclerosis Intervention Study. Lancet 2001, 357:905–910. ID - ref39 ER - TY - JOUR AU - Capuzzi, D. M. AU - Morgan, J. M. AU - Brusco, O. A. AU - Intenzo, C. M. PY - 2000 DA - 2000// TI - Niacin dosing: relationship to benefits and adverse effects JO - Curr Atheroscler Rep VL - 2 UR - https://doi.org/10.1007/s11883-000-0096-y DO - 10.1007/s11883-000-0096-y ID - Capuzzi2000 ER - TY - JOUR AU - Canner, P. L. AU - Berge, K. G. AU - Wenger, N. K. PY - 1986 DA - 1986// TI - Fifteen year mortality in coronary drug project patients: long-term benefit with niacin JO - JACC VL - 8 ID - Canner1986 ER - TY - JOUR AU - Carlson, L. A. AU - Rosenhamer, G. PY - 1988 DA - 1988// TI - Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid JO - Acta Med Scand VL - 223 UR - https://doi.org/10.1111/j.0954-6820.1988.tb15891.x DO - 10.1111/j.0954-6820.1988.tb15891.x ID - Carlson1988 ER - TY - JOUR AU - Elam, M. B. AU - Hunninghake, D. B. AU - Davis, K. B. PY - 2000 DA - 2000// TI - Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease. the ADMIT Study: a randomized trial JO - JAMA VL - 284 UR - https://doi.org/10.1001/jama.284.10.1263 DO - 10.1001/jama.284.10.1263 ID - Elam2000 ER -